MOTS-c.

MOTS-c signalling converges on AMP-activated protein kinase, the same energy sensor berberine activates by mildly restraining mitochondrial complex I and raising the AMP to ATP ratio. The overlap is a shared pathway rather than a measured combination.

MOTS-c signalling converges on AMPK, and NAD+ supply is upstream of the sirtuin arm that runs alongside it. Raising NAD+ precursor intake changes that upstream supply. No study has combined the two, so this is pathway overlap on paper and nothing more.

NMN feeds the same NAD+ pool that supports mitochondrial oxidative metabolism. MOTS-c work describes AMPK activation in that setting. The pairing is inferred from where each acts, not from a combination experiment.

Animal work on MOTS-c reports increased mitophagy, the recycling of damaged mitochondria. Urolithin A is studied for the same process through a different entry point. Two agents described as acting on one process is not evidence that they add together, and no combined data exists.

Several MOTS-c animal papers attribute the observed tissue effects to Nrf2 activation and the antioxidant response genes downstream of it. Sulforaphane is the classical dietary Nrf2 activator. Whether two Nrf2 inputs stack or saturate has not been tested.

Nrf2 activation raises transcription of glutathione synthesis enzymes, and cysteine is the rate-limiting substrate for that synthesis. A cysteine donor keeps the substrate side supplied. This is established biochemistry about the pathway, not evidence about the peptide.

Glutathione is built from glutamate, cysteine and glycine, which is settled biochemistry. Any pathway that raises glutathione synthesis draws on all three. Its relevance to MOTS-c is an inference from the Nrf2 findings in animals, so the pairing itself sits at early confidence.

The founding work on this peptide located its action in the folate-dependent one-carbon cycle, with accumulation of the AMPK activator AICAR as the reported consequence. Folate status is therefore part of the same system rather than a separate one. The direction of any interaction in a person is unknown and could run either way.

CoQ10 carries electrons between complexes I and II and complex III. MOTS-c work is framed around mitochondrial respiration and oxidative stress in the same organelle. Overlap of location is not evidence of a combined effect.

Lipoic acid is the covalently bound cofactor of pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, both inside mitochondria, and the free form is separately studied for AMPK effects. That places it in the same neighbourhood as the MOTS-c literature. No combination data exists.

Carnitine shuttles long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation, which is established. MOTS-c animal work reports shifts in substrate use. Pairing them is reasoning about substrate supply, not a tested combination.

Creatine phosphate buffers ATP in the cytosol while mitochondria regenerate it. Both are parts of one energy system. This is anatomy of the pathway, and no study has looked at the pair.

Taurine participates in the taurinomethyluridine modification of mitochondrial tRNA, which affects translation of mitochondrially encoded proteins. MOTS-c is itself encoded in mitochondrial DNA. The link is structural and speculative as a combination.

Resveratrol is studied as an indirect AMPK activator, and AMPK is the node most often reported downstream of MOTS-c. Two inputs to one kinase may add or may saturate. Nobody has measured which.

Astaxanthin partitions into membranes and is studied for mitochondrial oxidative measures. MOTS-c animal work centres on oxidative stress in the same compartment. Both sit in one compartment, which is where the similarity ends.